The OpenZone drug discovery unit will be used to support Enthera’s new discovery program and accelerate its mission to identify new treatments for intractable autoimmune diseases Milan, Italy, 7 July 2021 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing first-in-class biologics for selected autoimmune conditions based on the discovery of a novel apoptosis pathway, today […]
/wp-content/uploads/2019/10/logo_enthera.svg00hearten/wp-content/uploads/2019/10/logo_enthera.svghearten2021-07-06 16:38:172021-07-06 16:40:54Enthera Pharmaceuticals opens early drug discovery unit at OpenZone life sciences campus to expand autoimmune disease research
Milan, Italy, 1 April 2021 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing novel disease-modifying biologics that re-establish stem cell capabilities to treat specific autoimmune diseases, today announces the appointment of Claudia Nardini as Vice President of Research and Development to support the Company’s manufacturing and regulatory divisions. Claudia has 25 years of experience in […]
/wp-content/uploads/2019/10/logo_enthera.svg00hearten/wp-content/uploads/2019/10/logo_enthera.svghearten2021-04-01 09:00:432021-07-06 13:39:26Enthera Pharmaceuticals Appoints Claudia Nardini as Vice President of Research and Development
The Roche Venture Fund joins international investor syndicate, including co-lead investors Sofinnova Partners and AbbVie Ventures Funds to be used to advance restorative therapy for type 1 diabetes and inflammatory bowel disease Largest international VC-backed Series A financing round for a biotech in Italy to date and first ever venture investment in an Italian company […]
/wp-content/uploads/2019/10/logo_enthera.svg00hearten/wp-content/uploads/2019/10/logo_enthera.svghearten2021-01-28 09:00:522021-01-28 09:24:12Enthera Pharmaceuticals extends Series A financing, raising a total of €35 million
Enthera Pharmaceuticals opens early drug discovery unit at OpenZone life sciences campus to expand autoimmune disease research
/in Press Releases /by heartenThe OpenZone drug discovery unit will be used to support Enthera’s new discovery program and accelerate its mission to identify new treatments for intractable autoimmune diseases Milan, Italy, 7 July 2021 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing first-in-class biologics for selected autoimmune conditions based on the discovery of a novel apoptosis pathway, today […]
Enthera Pharmaceuticals Appoints Claudia Nardini as Vice President of Research and Development
/in Press Releases /by heartenMilan, Italy, 1 April 2021 – Enthera Pharmaceuticals (“Enthera”), a biotech company developing novel disease-modifying biologics that re-establish stem cell capabilities to treat specific autoimmune diseases, today announces the appointment of Claudia Nardini as Vice President of Research and Development to support the Company’s manufacturing and regulatory divisions. Claudia has 25 years of experience in […]
Enthera Pharmaceuticals extends Series A financing, raising a total of €35 million
/in Press Releases /by heartenThe Roche Venture Fund joins international investor syndicate, including co-lead investors Sofinnova Partners and AbbVie Ventures Funds to be used to advance restorative therapy for type 1 diabetes and inflammatory bowel disease Largest international VC-backed Series A financing round for a biotech in Italy to date and first ever venture investment in an Italian company […]